✦ LIBER ✦

Molecular evidence for Acanthocephala as a subtaxon of Rotifera

✍ Scribed by James R. Garey; Thomas J. Near; Michael R. Nonnemacher; Steven A. Nadler

Publisher: Springer
Year: 1996
Tongue: English
Weight: 612 KB
Volume: 43
Category: Article
ISSN: 0022-2844
DOI: 10.1007/bf02338837

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Evidence for a Clade of Turtle

Molecular Evidence for a Clade of Turtles

✍ Hideyuki Mannen; Steven S.-L. Li 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Although turtles have been generally grouped with the most primitive reptile species, the origin and phylogenetic relationships of turtles have remained unresolved to date. To confirm the phylogenetic position of turtles in amniotes, we have cloned and determined the cDNA sequences encoding for skin

Molecular Evidence for a Jurassic Origin

Molecular Evidence for a Jurassic Origin of Ants

✍ R. H. Crozier; L. S. Jermiin; M. Chiotis 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 31 KB

Molecular evidence for a viral etiology

Molecular evidence for a viral etiology of human CNS tumors

✍ W. Cuatico; J. -R. Cho; S. Spiegelman 📂 Article 📅 1976 🏛 Springer Vienna 🌐 English ⚖ 473 KB

Evidence for formation of Se molecular c

Evidence for formation of Se molecular clusters during

✍ Y. M. Azhniuk; A. V. Gomonnai; Y. I. Hutych; V. V. Lopushansky; L. A. Prots; I. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 381 KB

A Comparison of Potential Molecular Wire

A Comparison of Potential Molecular Wires as Components for Molecular Electronics

✍ Neil Robertson; Craig A. McGowan 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 56 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Functional evidence for Eme1 as a marker

Functional evidence for Eme1 as a marker of cisplatin resistance

✍ Yoshitaka Tomoda; Mari Katsura; Miyuki Okajima; Noriko Hosoya; Nobuoki Kohno; Ki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 182 KB

## Abstract The ability to predict cisplatin sensitivity in tumors has been expected to greatly improve the outcome of cancer therapy, because the drug is frequently used in a variety of tumors. Although ERCC1 and other repair proteins have been investigated as markers of cisplatin resistance, reli